'Day 34' presentation slideshows

438 views • 25 slides

Item

Durability of Effect in Double-blind Phase. Item. Active treatment. Placebo. value. P. 25% of patients had LTR. By day 34. By day 7. <0.0001. LTR by end of study. 32% of patients. 61% of patients. <0.0001. Worsening fatigue (MAF. By day 119. By day 27. <0.0001. scale).

144 views • 1 slides